適用於公開取用強制性政策的文章 - Esther Ooi瞭解詳情
未在任何資料庫公開的文章：9
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
EMM Ooi, PHR Barrett, DC Chan, GF Watts
Clinical science 114 (10), 611-624, 2008
授權規定： US National Institutes of Health
Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease
V Deshpande, A Huck, E Ooi, JH Stone, WC Faquin, GP Nielsen
Journal of clinical pathology 65 (8), 725-728, 2012
授權規定： National Health and Medical Research Council, Australia
The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies
EMM Ooi, PHR Barrett, GF Watts
International journal of cardiology 168 (3), 1811-1818, 2013
授權規定： National Health and Medical Research Council, Australia
Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men
EMM Ooi, GF Watts, DC Chan, LB Nielsen, P Plomgaard, B Dahlbäck, ...
Atherosclerosis 210 (1), 326-330, 2010
授權規定： Swedish Research Council
Consumption of a whey protein-enriched diet may prevent hepatic steatosis associated with weight gain in elderly women
EM Ooi, LA Adams, K Zhu, JR Lewis, DA Kerr, X Meng, V Solah, A Devine, ...
Nutrition, Metabolism and Cardiovascular Diseases 25 (4), 388-395, 2015
授權規定： National Health and Medical Research Council, Australia
Impact of pretransplant and new-onset diabetes after transplantation on the risk of major adverse cardiovascular events in kidney transplant recipients: a population-based …
WH Lim, CE Lok, SJ Kim, G Knoll, BR Shah, K Naylor, B Luo, M Vinegar, ...
Transplantation 105 (11), 2470-2481, 2021
授權規定： National Health and Medical Research Council, Australia, Canadian Institutes …
Lipoprotein (a) and Low‐density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein (a) and coronary artery disease
L Ma, E Waldmann, EMM Ooi, DC Chan, HPR Barrett, GF Watts, ...
European Journal of Clinical Investigation 49 (2), e13053, 2019
授權規定： National Health and Medical Research Council, Australia
Effect of the proton-pump Inhibitor pantoprazole on MycoPhenolic ACid exposure in kidney and liver transplant recipienTs (IMPACT study): a randomized trial
A Sunderland, G Russ, B Sallustio, M Cervelli, D Joyce, E Ooi, G Jeffrey, ...
Nephrology Dialysis Transplantation 35 (6), 1060-1070, 2020
授權規定： National Health and Medical Research Council, Australia
Fractional turnover of apolipoprotein (a) and apolipoprotein B-100 within plasma lipoprotein (a) particles in statin-treated patients with elevated and normal Lp (a) concentration
L Ma, DC Chan, EMM Ooi, PHR Barrett, GF Watts
Metabolism 96, 8-11, 2019
授權規定： National Health and Medical Research Council, Australia
在某個資料庫公開的文章：34
Effect of dietary fatty acids on human lipoprotein metabolism: a comprehensive update
EMM Ooi, GF Watts, TWK Ng, PHR Barrett
Nutrients 7 (6), 4416-4425, 2015
授權規定： National Health and Medical Research Council, Australia
Demystifying the management of hypertriglyceridaemia
GF Watts, EMM Ooi, DC Chan
Nature reviews Cardiology 10 (11), 648-661, 2013
授權規定： National Health and Medical Research Council, Australia
Plasma phospholipid fatty acid biomarkers of dietary fat quality and endogenous metabolism predict coronary heart disease risk: a nested case‐control study within the Women's …
NR Matthan, EM Ooi, L Van Horn, ML Neuhouser, R Woodman, ...
Journal of the American Heart Association 3 (4), e000764, 2014
授權規定： US National Institutes of Health, National Health and Medical Research …
Dose-dependent effects of rosuvastatin on the plasma sphingolipidome and phospholipidome in the metabolic syndrome
TWK Ng, EMM Ooi, GF Watts, DC Chan, JM Weir, PJ Meikle, PHR Barrett
The Journal of Clinical Endocrinology & Metabolism 99 (11), E2335-E2340, 2014
授權規定： National Health and Medical Research Council, Australia
Effects of Extended-Release Niacin on the Postprandial Metabolism of Lp (a) and ApoB-100–Containing Lipoproteins in Statin-Treated Men With Type 2 Diabetes Mellitus
EM Ooi, GF Watts, DC Chan, J Pang, VS Tenneti, SJ Hamilton, ...
Arteriosclerosis, thrombosis, and vascular biology 35 (12), 2686-2693, 2015
授權規定： National Health and Medical Research Council, Australia
Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin1
N Thongtang, MR Diffenderfer, EMM Ooi, PHR Barrett, SM Turner, NA Le, ...
Journal of lipid research 58 (7), 1315-1324, 2017
授權規定： US National Institutes of Health, US Department of Agriculture
Dietary fatty acids and lipoprotein metabolism: new insights and updates
EMM Ooi, TWK Ng, GF Watts, PHR Barrett
Current opinion in lipidology 24 (3), 192-197, 2013
授權規定： National Health and Medical Research Council, Australia
Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome
DC Chan, GF Watts, EMM Ooi, J Ji, AG Johnson, PHR Barrett
Arteriosclerosis, thrombosis, and vascular biology 28 (10), 1831-1837, 2008
授權規定： US National Institutes of Health
Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin
D Sviridov, A Hoang, E Ooi, G Watts, PHR Barrett, P Nestel
Atherosclerosis 197 (2), 732-739, 2008
授權規定： US National Institutes of Health
Elevated remnant cholesterol in 25-hydroxyvitamin D deficiency in the general population: Mendelian randomization study
EM Ooi, S Afzal, BG Nordestgaard
Circulation: Cardiovascular Genetics 7 (5), 650-658, 2014
授權規定： National Health and Medical Research Council, Australia, Danish Council for …
Effects of therapeutic lifestyle change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects
EMM Ooi, AH Lichtenstein, JS Millar, MR Diffenderfer, S Lamon-Fava, ...
Journal of lipid research 53 (9), 1958-1967, 2012
授權規定： US National Institutes of Health, National Health and Medical Research …
出版品和資金資訊是由電腦程式自動估算而得